- Home
- ARMP vs DIBS Comparison
ARMP vs DIBS Comparison
Compare ARMP & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- DIBS
- Stock Information
- Founded
- ARMP N/A
- DIBS 2000
- Country
- ARMP United States
- DIBS United States
- Employees
- ARMP N/A
- DIBS N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- DIBS Catalog/Specialty Distribution
- Sector
- ARMP Health Care
- DIBS Consumer Discretionary
- Exchange
- ARMP Nasdaq
- DIBS Nasdaq
- Market Cap
- ARMP 92.4M
- DIBS 96.8M
- IPO Year
- ARMP N/A
- DIBS 2021
- Fundamental
- Price
- ARMP $2.61
- DIBS $2.66
- Analyst Decision
- ARMP Strong Buy
- DIBS Hold
- Analyst Count
- ARMP 1
- DIBS 1
- Target Price
- ARMP $9.00
- DIBS N/A
- AVG Volume (30 Days)
- ARMP 9.3K
- DIBS 50.7K
- Earning Date
- ARMP 08-12-2025
- DIBS 08-06-2025
- Dividend Yield
- ARMP N/A
- DIBS N/A
- EPS Growth
- ARMP N/A
- DIBS N/A
- EPS
- ARMP N/A
- DIBS N/A
- Revenue
- ARMP $6,868,000.00
- DIBS $88,640,000.00
- Revenue This Year
- ARMP $8.43
- DIBS $3.02
- Revenue Next Year
- ARMP N/A
- DIBS $6.51
- P/E Ratio
- ARMP N/A
- DIBS N/A
- Revenue Growth
- ARMP 84.67
- DIBS 3.21
- 52 Week Low
- ARMP $0.90
- DIBS $2.30
- 52 Week High
- ARMP $2.96
- DIBS $5.00
- Technical
- Relative Strength Index (RSI)
- ARMP 58.67
- DIBS 49.74
- Support Level
- ARMP $2.43
- DIBS $2.54
- Resistance Level
- ARMP $2.72
- DIBS $2.70
- Average True Range (ATR)
- ARMP 0.18
- DIBS 0.13
- MACD
- ARMP -0.01
- DIBS 0.00
- Stochastic Oscillator
- ARMP 70.08
- DIBS 48.15
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.